Daniel Dedman

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

BMJ open

Clinical epidemiology

International journal of chronic obstructive pulmonary disease

Pulmonary therapy

Medicines and Healthcare Products Regulatory Agency

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medicines and Healthcare Products Regulatory Agency Sep 12 2011

United Kingdom

Senior Researcher :: Clinical Practice Research Datalink (CPRD)

Publications

Daniel Dedman, Rachael Williams, Krishnan Bhaskaran, Ian J Douglas
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases. BMJ open 14 (2) (2024)
Daniel Dedman, Rachael Williams, Krishnan Bhaskaran, Ian J Douglas
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases. BMJ open 14 (2) (2024)
Daniel Dedman, Rachael Williams, Krishnan Bhaskaran, Ian J Douglas
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases. BMJ open 14 (2) (2024)
Alejandro Arana, Jesper Hallas, Josephina G Kuiper, Helen Booth, Johan Reutfors, Brian Calingaert, Lars Christian Lund, Elizabeth Crellin, Marcus Schmitt-Egenolf, James A Kaye, Karin Gembert, Kenneth J Rothman, Helle Kieler, Daniel Dedman, Eline Houben, Lia Gutiérrez, Nina Sahlertz Kristiansen, Susanna Perez-Gutthann
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical epidemiology 13 (2021)
Danielle E Robinson, M Sanni Ali, Victoria Y Strauss, Leena El-Hussein, Bo Abrahamsen, Nigel K Arden, Yoav Ben-Shlomo, Fergus John Caskey, Cyrus Cooper, Daniel Dedman, Antonella Delmestri, Andrew Judge, Muhammad Kassim Javaid, Daniel Prieto Alhambra
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study. Health technology assessment (Winchester, England) 25 (17) (2021)
Gema Requena, Daniel Dedman, Jennifer Kathleen Quint, Rebecca Elisabeth Ghosh, Rachael Williams, Jeanne M Pimenta
The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study. International journal of chronic obstructive pulmonary disease 16 (2021)
Daniel Dedman, Melissa Cabecinha, Rachael Williams, Stephen J W Evans, Krishnan Bhaskaran, Ian J Douglas
Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies. BMJ open 10 (10) (2020)
Edith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra, Elisabeth Smits, Helen P Booth, Daniel Dedman, Ying He, Fabian Hoti, Minna Vehkala, Stefan de Vogel, Noah Jamie Robinson, Kwame Appenteng, Fernie J A Penning-van Beest
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries. Clinical epidemiology 12 (2020)
Daniel Dedman, Sonia J Coton, Rebecca E Ghosh, Wilhelmine Meeraus, Courtney Crim, Catherine Harvey, Justyna Amelio, Sarah H Landis
Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study. Pulmonary therapy 5 (1) (2019)

Daniel Dedman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Dedman